98 related articles for article (PubMed ID: 16582572)
1. Relation between different treatment modalities and genomic damage of end-stage renal failure patients.
Kobras K; Schupp N; Nehrlich K; Adelhardt M; Bahner U; Vienken J; Heidland A; Sebekova K; Stopper H
Kidney Blood Press Res; 2006; 29(1):10-7. PubMed ID: 16582572
[TBL] [Abstract][Full Text] [Related]
2. Effect of different hemodialysis regimens on genomic damage in end-stage renal failure.
Schupp N; Stopper H; Rutkowski P; Kobras K; Nebel M; Bahner U; Vienken J; Heidland A
Semin Nephrol; 2006 Jan; 26(1):28-32. PubMed ID: 16412822
[TBL] [Abstract][Full Text] [Related]
3. Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis.
Fragedaki E; Nebel M; Schupp N; Sebekova K; Völkel W; Klassen A; Pischetsrieder M; Frischmann M; Niwa T; Vienken J; Heidland A; Stopper H
Nephrol Dial Transplant; 2005 Sep; 20(9):1936-43. PubMed ID: 15919695
[TBL] [Abstract][Full Text] [Related]
4. New approaches for the treatment of genomic damage in end-stage renal disease.
Schupp N; Schmid U; Heidland A; Stopper H
J Ren Nutr; 2008 Jan; 18(1):127-33. PubMed ID: 18089459
[TBL] [Abstract][Full Text] [Related]
5. Reduction of the genomic damage level in haemodialysis patients by folic acid and vitamin B12 supplementation.
Stopper H; Treutlein AT; Bahner U; Schupp N; Schmid U; Brink A; Perna A; Heidland A
Nephrol Dial Transplant; 2008 Oct; 23(10):3272-9. PubMed ID: 18469307
[TBL] [Abstract][Full Text] [Related]
6. Genomic damage in endothelial progenitor cells from uremic patients in hemodialysis.
Buemi M; Costa C; Floccari F; Coppolino G; Campo S; Bolignano D; Sturiale A; Lacquaniti A; Buemi A; Loddo S; Teti D
J Nephrol; 2010; 23(3):328-34. PubMed ID: 20301080
[TBL] [Abstract][Full Text] [Related]
7. Dialysis-related genotoxicity: sister chromatid exchanges and DNA lesions in T and B lymphocytes of uremic patients. Genomic damage in patients on hemodiafiltration.
Buemi M; Floccari F; Costa C; Caccamo C; Belghity N; Campo S; Pernice F; Bonvissuto G; Coppolino G; Barillà A; Criseo M; Crascì E; Nostro L; Arena A
Blood Purif; 2006; 24(5-6):569-74. PubMed ID: 17124425
[TBL] [Abstract][Full Text] [Related]
8. Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis.
Gerdemann A; Lemke HD; Nothdurft A; Heidland A; Münch G; Bahner U; Schinzel R
Clin Nephrol; 2000 Oct; 54(4):276-83. PubMed ID: 11076103
[TBL] [Abstract][Full Text] [Related]
9. Enhanced plasma levels of advanced glycation end products (AGE) and pro-inflammatory cytokines in children/adolescents with chronic renal insufficiency and after renal replacement therapy by dialysis and transplantation--are they inter-related?
Sebeková K; Podracká L; Heidland A; Schinzel R
Clin Nephrol; 2001 Dec; 56(6):S21-6. PubMed ID: 11770807
[TBL] [Abstract][Full Text] [Related]
10. Pilot study for comparison of reticulocyte-micronulei with lymphocyte-micronuclei in human biomonitoring.
Stopper H; Hempel K; Reiners C; Vershenya S; Lorenz R; Vukicevic V; Heidland A; Grawe J
Toxicol Lett; 2005 Apr; 156(3):351-60. PubMed ID: 15763634
[TBL] [Abstract][Full Text] [Related]
11. Genetic damage in patients moving from hemodialysis to online hemodiafiltration.
Rodríguez-Ribera L; Pastor S; Corredor Z; Silva I; Diaz JM; Ballarin J; Marcos R; Coll E
Mutagenesis; 2016 Mar; 31(2):131-5. PubMed ID: 26285921
[TBL] [Abstract][Full Text] [Related]
12. Genomic damage and malignancy in end-stage renal failure: do advanced glycation end products contribute?
Sebeková K; Wagner Z; Schupp N; Boor P
Kidney Blood Press Res; 2007; 30(1):56-66. PubMed ID: 17261927
[TBL] [Abstract][Full Text] [Related]
13. Comet-assay analysis identifies genomic damage in lymphocytes of uremic patients.
Stopper H; Boullay F; Heidland A; Vienken J; Bahner U
Am J Kidney Dis; 2001 Aug; 38(2):296-301. PubMed ID: 11479155
[TBL] [Abstract][Full Text] [Related]
14. Levels of DNA damage in peripheral blood lymphocytes of patients undergoing standard hemodialysis vs on-line hemodiafiltration: A comet assay investigation.
Corredor Z; Rodríguez-Ribera L; Silva I; Díaz JM; Ballarín J; Marcos R; Coll E; Pastor S
Mutat Res Genet Toxicol Environ Mutagen; 2016 Sep; 808():1-7. PubMed ID: 27637480
[TBL] [Abstract][Full Text] [Related]
15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
16. Genomic damage in chronic renal failure--potential therapeutic interventions.
Stopper H; Schupp N; Klassen A; Sebekova K; Heidland A
J Ren Nutr; 2005 Jan; 15(1):81-6. PubMed ID: 15648013
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress, sister chromatid exchanges and apoptosis in the pathogenesis of lymphocytopenia in ESRD patients.
Pernice F; Floccari F; Nostro L; Caccamo C; Belghity N; Mantuano S; Romeo A; Barilla' A; Aloisi C; Ruello A; Frisina N; Buemi M
J Nephrol; 2006; 19(5):613-20. PubMed ID: 17136690
[TBL] [Abstract][Full Text] [Related]
18. Effect of sevelamer and calcium-based phosphate binders on coronary artery calcification and accumulation of circulating advanced glycation end products in hemodialysis patients.
Kakuta T; Tanaka R; Hyodo T; Suzuki H; Kanai G; Nagaoka M; Takahashi H; Hirawa N; Oogushi Y; Miyata T; Kobayashi H; Fukagawa M; Saito A
Am J Kidney Dis; 2011 Mar; 57(3):422-31. PubMed ID: 21239096
[TBL] [Abstract][Full Text] [Related]
19. Assessment of peripheral DNA damage by alkaline comet assay in maintenance hemodialysis subjects with hepatitis C infection.
Horoz M; Bolukbas C; Bolukbas FF; Kocyigit A; Aslan M; Koylu AO; Gumus M; Celik H; Koksal M
Mutat Res; 2006 Apr; 596(1-2):137-42. PubMed ID: 16458331
[TBL] [Abstract][Full Text] [Related]
20. Time in hemodialysis modulates the levels of genetic damage in hemodialysis patients.
Rodríguez-Ribera L; Stoyanova E; Corredor Z; Coll E; Silva I; Diaz JM; Ballarin J; Marcos R; Pastor S
Environ Mol Mutagen; 2014 May; 55(4):363-8. PubMed ID: 24436196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
